JP2004509961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004509961A5 JP2004509961A5 JP2002531121A JP2002531121A JP2004509961A5 JP 2004509961 A5 JP2004509961 A5 JP 2004509961A5 JP 2002531121 A JP2002531121 A JP 2002531121A JP 2002531121 A JP2002531121 A JP 2002531121A JP 2004509961 A5 JP2004509961 A5 JP 2004509961A5
- Authority
- JP
- Japan
- Prior art keywords
- thiazolidine
- pyridyl
- ethoxy
- benzyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN805CH2000 | 2000-09-26 | ||
| PCT/US2001/029896 WO2002026737A1 (en) | 2000-09-26 | 2001-09-25 | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004509961A JP2004509961A (ja) | 2004-04-02 |
| JP2004509961A5 true JP2004509961A5 (https=) | 2008-11-06 |
Family
ID=29266775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002531121A Pending JP2004509961A (ja) | 2000-09-26 | 2001-09-25 | ５−［４−［２−［ｎ−メチル−ｎ−（２−ピリジル）アミノ］エトキシ］ベンジル］チアゾリジン−２，４−ジオンマレイン酸塩の新規の多型形態およびそれらの調製方法 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1322647A1 (https=) |
| JP (1) | JP2004509961A (https=) |
| AU (1) | AU9123201A (https=) |
| BR (1) | BR0114196A (https=) |
| CA (1) | CA2426117A1 (https=) |
| CZ (1) | CZ2003864A3 (https=) |
| HU (1) | HUP0301161A3 (https=) |
| IL (1) | IL155036A0 (https=) |
| MX (1) | MXPA03002580A (https=) |
| NO (1) | NO324968B1 (https=) |
| NZ (1) | NZ525498A (https=) |
| PL (1) | PL360661A1 (https=) |
| SK (1) | SK3752003A3 (https=) |
| WO (1) | WO2002026737A1 (https=) |
| ZA (1) | ZA200303223B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726563D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| UA67844C2 (uk) | 1999-04-23 | 2004-07-15 | Смітклайн Бічам Плс | Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти |
| EP1903043A1 (en) | 1999-04-23 | 2008-03-26 | SmithKline Beecham P.L.C. | Novel pharmaceutical |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
| US20030171399A1 (en) | 2000-06-28 | 2003-09-11 | Tularik Inc. | Quinolinyl and benzothiazolyl modulators |
| WO2004062667A1 (en) * | 2003-01-08 | 2004-07-29 | Dr. Reddy's Laboratories Limited | Amorphous form of rosiglitazone maleate and process for preparation thereof |
| GB0307259D0 (en) * | 2003-03-28 | 2003-05-07 | Glaxo Group Ltd | Process |
| EP1468997A3 (en) * | 2003-04-18 | 2004-11-03 | CHEMI S.p.A. | Polymorphous forms of rosiglitazone maleate |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| US7223761B2 (en) | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
| AR047541A1 (es) * | 2004-02-13 | 2006-01-25 | Sandoz Ag | Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas |
| WO2005095390A2 (en) * | 2004-03-31 | 2005-10-13 | Sandoz Ag | Novel co-precipitate of amorphous rosiglitazone |
| EP1757603A4 (en) * | 2004-05-11 | 2008-06-25 | Santen Pharmaceutical Co Ltd | THERAPEUTIC AGENT FOR KERAATOCONJUNCTIVITIS AFFECTION |
| JP2005350451A (ja) * | 2004-05-11 | 2005-12-22 | Santen Pharmaceut Co Ltd | 角結膜障害治療剤 |
| CZ296472B6 (cs) * | 2004-07-27 | 2006-03-15 | Zentiva, A. S | Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0842925A1 (en) * | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| JP2000511875A (ja) * | 1996-06-19 | 2000-09-12 | ドクター・レディーズ・リサーチ・ファウンデーション | 抗糖尿病活性を増強されたトログリタゾンの新規な多形型及びそれらの製造方法 |
| JP2000514041A (ja) * | 1996-07-26 | 2000-10-24 | ドクター・レディーズ・リサーチ・ファウンデーション | 抗糖尿病、低脂血、抗高血圧特性を有するチアゾリジンジオン化合物、それらの調製法、及びその薬学的組成物 |
| GB9726566D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| EP1903043A1 (en) * | 1999-04-23 | 2008-03-26 | SmithKline Beecham P.L.C. | Novel pharmaceutical |
| UA67844C2 (uk) * | 1999-04-23 | 2004-07-15 | Смітклайн Бічам Плс | Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти |
-
2001
- 2001-09-25 CZ CZ2003864A patent/CZ2003864A3/cs unknown
- 2001-09-25 IL IL15503601A patent/IL155036A0/xx unknown
- 2001-09-25 PL PL01360661A patent/PL360661A1/xx not_active Application Discontinuation
- 2001-09-25 NZ NZ525498A patent/NZ525498A/en unknown
- 2001-09-25 AU AU9123201A patent/AU9123201A/xx active Pending
- 2001-09-25 JP JP2002531121A patent/JP2004509961A/ja active Pending
- 2001-09-25 WO PCT/US2001/029896 patent/WO2002026737A1/en not_active Ceased
- 2001-09-25 EP EP01971336A patent/EP1322647A1/en not_active Withdrawn
- 2001-09-25 BR BR0114196-1A patent/BR0114196A/pt not_active Application Discontinuation
- 2001-09-25 CA CA002426117A patent/CA2426117A1/en not_active Abandoned
- 2001-09-25 SK SK375-2003A patent/SK3752003A3/sk not_active Application Discontinuation
- 2001-09-25 HU HU0301161A patent/HUP0301161A3/hu unknown
- 2001-09-25 MX MXPA03002580A patent/MXPA03002580A/es active IP Right Grant
-
2003
- 2003-03-25 NO NO20031356A patent/NO324968B1/no unknown
- 2003-04-24 ZA ZA200303223A patent/ZA200303223B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004509961A5 (https=) | ||
| RU2001130883A (ru) | Новые полиморфные формы антидиабетического средства, способ их получения и содержащие их фармацевтические композиции | |
| TW201121544A (en) | Novel phenol derivative | |
| WO2000071540A1 (en) | Hydrochloride of fused-heterocycle compound | |
| JP2004509961A (ja) | ５−［４−［２−［ｎ−メチル−ｎ−（２−ピリジル）アミノ］エトキシ］ベンジル］チアゾリジン−２，４−ジオンマレイン酸塩の新規の多型形態およびそれらの調製方法 | |
| WO2008016175A1 (en) | Activator for peroxisome proliferator activated receptor | |
| JP2008539278A (ja) | 結晶性ロスバスタチンカルシウム | |
| US7598387B2 (en) | Synthesis of antidiabetic rosiglitazone derivatives | |
| JP2003531200A (ja) | 糖尿病、高脂血症、高コレステロール血症、およびアテローム性動脈硬化症の治療のための材料と方法 | |
| JP2004520393A5 (https=) | ||
| JP2005523300A5 (https=) | ||
| JP4634716B2 (ja) | ５−［４−［［３−メチル−４−オキソ−３，４−ジヒドロキナゾリン−２−イル］メトキシ］ベンジル］チアゾリジン−２，４−ジオンカリウム塩の新規な結晶形 | |
| WO2002028857A1 (en) | Polymorphs of pioglitazone hydrochloride and their use as antidiabetics | |
| RU2003112226A (ru) | Новые полиморфоные форы 5-[4-2-[n-метил-n-(2-пиридил)амино]этокси]тиазолидин-2,4-дион малеата и способ их получения | |
| KR20100098709A (ko) | 독사조신 메실레이트의 결정 다형(형태 ｉｖ) 및 이의 제조방법 | |
| KR20020022812A (ko) | 티아졸리딘디온 유도체를 함유하는 제약 조성물 및 그의제조 방법 | |
| RU2286345C2 (ru) | Полиморфные кристаллические формы 5-[4-2-[n-метил-n-(2-пиридил)амино]этокси]бензил]тиазолидин-2,4-дион малеата | |
| JP3884736B2 (ja) | ハロゲノベンジルアミノプロピオン酸誘導体 | |
| CN101395145A (zh) | 新的杂环的环烷基衍生物、制备其的方法和包含其的药物组合物 | |
| WO2015106674A1 (zh) | 一种安塞曲匹的晶型及其制备方法、其药物组合物和用途 | |
| EA051917B1 (ru) | Новая соль соединения-агониста рецептора гпп-1, способ ее получения и содержащая ее фармацевтическая композиция | |
| AU2002241506B2 (en) | Atorvastatin hemi-calcium form VII | |
| WO2003066612A1 (en) | Novel polymorphic forms of bicyclic antidiabetic agents: process for their preparation and pharmaceutical compositions containing them | |
| JPH083152A (ja) | アルキレンジアミン誘導体 | |
| HK1235776B (zh) | 唑苯衍生物的晶体 |